(RTTNews) - CollPlant Biotechnologies (CLGN) posted a second quarter net loss of $4.21 million or $0.37 per share compared to profit of $5.76 million or $0.49 per share, a year ago. Non-GAAP net loss was $3.8 million, or $0.33 per share, compared to net income of $6.0 million, or $0.53 basic per share, prior year.
Revenue was $249 thousand compared to $10.18 million. The company said the decrease in revenues is mainly related to the achievement of a milestone with respect to the AbbVie agreement, which triggered a $10 million payment in 2023.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
